Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. PDF Solutions (PDFS) just reported record fourth quarter and full year 2025 ...

We’ll explore how Array’s integration of APA’s fixed-tilt and A-frame designs opens new possibilities in difficult terrains and why foundation choice is critical to structural resilience and long-term ...

There are two key things to know about the new Applied Biosystems™ SwiftArrayStudio™ Microarray Analyzer from Thermo Fisher Scientific, said Ravi Gupta, vice president and general manager of Thermo ...

Get any of our free daily email newsletters — news headlines, opinion, e-edition, obituaries and more. We are in a housing crisis. While the poorest among us feel these consequences most sharply, the ...

Add Yahoo as a preferred source to see more of our stories on Google. A new report suggests increased investments in solar power on school grounds could help reduce energy costs in Centre County and ...

Array Technologies Inc. (NASDAQ:ARRY) is one of the best solar stocks to buy according to Wall Street analysts. On August 14, Array Technologies announced the successful completion of its acquisition ...

Management reiterated the goal to achieve positive free cash flow by Q4 2025, with McCormack stating, “we remain on track to deliver positive free cash flow by Q4 2025.” Beck indicated, “we still ...

“In the first half of 2025, VIQ delivered 164% growth in Adjusted EBITDA, expanded gross margins to nearly 50%, and achieved our fifth consecutive quarter of positive EBITDA,” said Alexie Edwards, CFO ...

Albuquerque-based Array Technologies reported Thursday a 20% jump in revenue from the previous quarter, beating analyst expectations. In an earnings call, company officials reported $362.2 million in ...

Opus Genetics, Inc. announced positive topline results from its VEGA-3 Phase 3 clinical trial evaluating Phentolamine Ophthalmic Solution 0.75% for treating presbyopia, achieving its primary and key ...

VEGA-3 trial showed significant efficacy of phentolamine ophthalmic solution 0.75% in improving near vision in presbyopia patients compared to placebo. The trial met its primary endpoint with 27.2% ...